Clinical trial focuses on reducing overactive immune response in COVID-19
Researchers at Washington University School of Medicine in St. Louis are investigating whether a drug approved by the Food and Drug Administration (FDA) to treat rare diseases of an overactive immune system could help critically ...
Aug 17, 2020
0
10